Population pharmacokinetic modeling of GS‐441524, the active metabolite of remdesivir, in Japanese COVID‐19 patients with renal dysfunction
2016 ◽
Vol 42
(1)
◽
pp. 171-171
2016 ◽
Vol 42
(4)
◽
pp. 573-581
◽
2017 ◽
Vol 42
(6)
◽
pp. 1019-1021
◽
2018 ◽
Vol Volume 11
◽
pp. 3061-3070
◽
2015 ◽
Vol 41
(4)
◽
pp. 345-351
◽
2016 ◽
Vol 33
(7)
◽
pp. 1657-1670
◽